CMS continues to push its national interoperability framework, setting clear standards for how payers, hospital systems, software vendors, and health data networks share patient information.
While the rules began as voluntary guidance, they have quickly become the baseline expectation for compliance, reimbursement, and M&A valuations across digital health.
Key Areas of Focus:
1. Direct Patient Record Access
Verified digital credentials let patients pull and move their medical histories across different healthcare systems without administrative delays.
2. Real-Time Data Exchange
Participating systems are expected to support FHIR-based APIs and active record locators to enable instant communication between software platforms.
3. Broader Data Usage Rights
Providers, ACOs, and value-based care groups can access clinical and billing records faster to streamline patient treatment and administrative workflows.
4. Public Directories & Governance
CMS is driving greater transparency around national provider directories, access audit trails, and data usage tracking.
5. Security & Identity Verification
Strict credentialing, audit trails, and HIPAA-compliant consent protocols are standard across all network participants.
M&A Implications for Healthtech Founders
Buyers and private equity sponsors are paying close attention to which software platforms meet these standards and which ones rely on outdated, closed systems:
* Demand for Data Enablers: Strategic buyers are paying premiums for platforms that handle secure data exchange, patient identity, and API integration.
* Discounting Legacy Software: Acquirers view non-interoperable software as a risk. If a buyer has to rebuild code post-closing to meet federal data standards, that cost comes directly off the purchase price.
* Transaction Readiness: Proving your technology is compliant removes a primary due diligence risk and helps protect valuation during negotiations.
The regulatory trajectory set by CMS is clear: interoperability is no longer an operational bonus, but a foundational requirement for healthtech businesses. Strategic buyers and private equity sponsors are actively pricing this reality into their acquisitions. Companies with open, compliant data architectures are capturing premium valuations, while legacy platforms face steep price adjustments during due diligence.
For founders preparing for an exit over the next 12 to 24 months, addressing technical compliance and data-sharing standards early is essential to protecting transaction value and ensuring a clean closing process.